Batch of betaxolol tablets recalled over possible oxycodone contamination

Betaxolol tablets recall overview: 

• Who: KVK-Tech recalled one batch of its betaxolol tablets, USP 10 milligrams. 
• Why: The company initiated the recall as a precautionary measure after it found a single Oxycodone HCI tablet in the packaging line.  
• Where: The recall affects consumers nationwide. 

Pharmaceutical company KVK-Tech initiated a voluntary nationwide recall for one batch of its Betaxolol Tablets, USP 10 milligrams, as a precautionary measure after the company found a single oxycodone HCI tablet in its packaging line during line clearance after the lot was packaged. 

The recall, which the U.S. Food and Drug Administration published Oct. 3, involves betaxolol tablets, USP 10 milligrams, with batch no. 17853A and expiration date June 2027.

KVK says it has not received any reports of a foreign tablet being found in a bottle of the recalled betaxolol tablets. 

The company, which says it distributed the recalled betaxolol tablets nationwide to retailers and wholesalers, notified its distributors and customers about the recall through email and with a letter sent on Sept. 26, according to the betaxolol recall. 

Consumers advised to stop using recalled betaxolol tablets, return for full refund

Consumers who received the recalled betaxolol tablets should stop using them and immediately return them to KVK, which said it will arrange for a full refund, the recall notice states. 

Individuals with more questions about the recall can contact KVK by telephone at 215-579-1842, extension 6002, or by email. 

In another recall involving tablets, Lupin recalled two batches of its Tydemy contraceptive pills in August over concerns they could contain low levels of inactive content, which could impact their effectiveness. 

Are you impacted by the betaxolol recall? Let us know in the comments. 

Read About More Class Action Lawsuits & Class Action Settlements:

• Biomic Sciences initiates recall for nasal sprays due to microbial contamination
• Tylenol, Mucinex buyer files class action lawsuit over allegedly ineffective ingredient
• Recall initiated for Brexafemme antifungal tablets due to possible cross contamination
• Eli Lilly files 10 lawsuits over diabetes drug counterfeits, compounds